Breast Dense Tissue Segmentation

Breast Dense Tissue Segmentation segments dense tissue and the overall breast area in digital mammograms using a confusion matrix (CM)-YNet deep learning model to quantify breast density for breast cancer risk assessment.


Key Features:

  • Automated segmentation: Automatically identifies and segments the overall breast area and dense tissue within digital mammograms.
  • CM-YNet deep learning: Implements a confusion matrix (CM)-YNet model to handle noisy labels by modeling each radiologist's labels for improved ground-truth estimation.
  • Breast detection and pectoral muscle exclusion: Includes explicit breast detection and exclusion of the pectoral muscle to restrict segmentation to relevant breast tissue.

Scientific Applications:

  • Breast cancer risk assessment: Provides quantitative breast density measurements to support identification of individuals at elevated risk for breast cancer.
  • Research and clinical studies: Produces reliable segmentation outputs for multi-center studies and clinical research on the relationship between breast density and cancer incidence.

Methodology:

The workflow uses a confusion matrix (CM)-YNet model that models each radiologist’s labels to address label variability, includes breast detection and pectoral muscle exclusion, and was validated on a multi-center mammogram corpus with an average DICE score of 0.82.

Topics

Collections

Details

License:
Proprietary
Maturity:
Mature
Tool Type:
command-line tool
Operating Systems:
Windows, Mac, Linux
Programming Languages:
Python
Added:
5/22/2025
Last Updated:
11/12/2025

Operations

Data Inputs & Outputs

Publications

Larroza A, Pérez-Benito FJ, Perez-Cortes J, Román M, Pollán M, Pérez-Gómez B, Salas-Trejo D, Casals M, Llobet R. Breast Dense Tissue Segmentation with Noisy Labels: A Hybrid Threshold-Based and Mask-Based Approach. Diagnostics. 2022;12(8):1822. doi:10.3390/diagnostics12081822. PMID:36010173. PMCID:PMC9406546.

PMID: 36010173
PMCID: PMC9406546
Funding: - Valencian technological innovation centres: (PI17/00047), IMDEEA/2021/100 - Instituto de Salud Carlos III FEDER: (PI17/00047), IMDEEA/2021/100

Documentation

Links